Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

Company Performance - Sensus Healthcare, Inc. reported a quarterly loss of $0.06 per share, missing the Zacks Consensus Estimate of $0.01, and compared to earnings of $0.10 per share a year ago, representing an earnings surprise of -700.00% [1] - The company posted revenues of $7.32 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 16.88%, and down from $9.24 million year-over-year [2] - Over the last four quarters, Sensus Healthcare has surpassed consensus EPS estimates only once and has topped consensus revenue estimates three times [2] Stock Outlook - Sensus Healthcare shares have declined approximately 23% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.07 on revenues of $9.92 million, and for the current fiscal year, it is $0.11 on revenues of $41.95 million [7] - The estimate revisions trend for Sensus Healthcare was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Instruments industry, to which Sensus Healthcare belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]